30mg Librela Solution for Dogs - 2 Vials
370964
30mg Librela for Dogs is a vet-prescribed monthly injection that targets Nerve Growth Factor (NGF) to relieve osteoarthritis pain in dogs, helping improve comfort, mobility and daily activity at home.
Librela is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.
Osteoarthritis (Arthritis) is a long-term joint condition. In a healthy joint, smooth cartilage covers the ends of the bones and helps them glide with minimal friction. The joint also contains lubricating fluid and supportive tissues that keep movement stable. With osteoarthritis, cartilage gradually becomes damaged and less effective at cushioning. The joint lining can become inflamed, the joint can thicken, and movement can become painful and stiff. Dogs may avoid using the joint fully, which can lead to reduced muscle strength and poorer joint stability.
Osteoarthritis is common in older dogs, but it can develop at any age. Previous joint injury, repeated strain, and inherited joint conformation issues (such as hip or elbow dysplasia) can all contribute. Excess body weight is also important because it increases the load on painful joints and can worsen stiffness.
Librela 30mg contains bedinvetmab, which is a monoclonal antibody. Monoclonal antibodies are designed to target a specific molecule in the body. Bedinvetmab targets nerve growth factor (NGF), a signalling molecule involved in pain pathways. In osteoarthritis, NGF can contribute to ongoing pain by increasing the sensitivity of nerves in and around affected joints.
Because osteoarthritis is ongoing, Librela is usually repeated every month to help maintain consistent pain control. Your vet may suggest tracking changes in your dog’s daily activity and comfort, because gradual improvements can be easier to spot when you look back over a few weeks. If your dog’s mobility suddenly worsens, if they show new pain, or if you notice any change that concerns you, you should contact your veterinary practice for advice.
Product Features
- Pack Size: - Pack of 2
- Target Animal: - Dog (Canine)
- Related Condition: - Osteoarthritis in Dogs
- Pet Prescription Required?: - Yes
- Active Ingredient: - Bedinvetmab
- Product Name: - Librela solution for injection for dogs
More Information
Description
30mg Librela for Dogs is a veterinary medicine used to help control pain associated with osteoarthritis. It is supplied as an injectable solution. The 30mg strength is one of several vial sizes that helps your vet select an accurate dose based on your dog's body weight. Librela is usually given as a once-monthly injection by a veterinary professional as part of a wider plan to support comfort and mobility.
Dogs often show joint pain as changes in movement or behaviour rather than obvious yelping. Stiffness after rest is common, especially first thing in the morning. Limping may be worse after exercise, or a dog may simply become slower and less keen to play. Some dogs hesitate before jumping into the car, climbing stairs, or getting on furniture. Others seem quieter than usual, lick at a sore area, or become less tolerant of being touched around the hips, knees, elbows, or back end.
A vet will usually diagnose osteoarthritis by combining the history, a physical examination, and sometimes imaging such as X-rays. The aim of treatment is to reduce pain, support daily movement, and slow the cycle of stiffness and muscle loss as much as possible.
Bedinvetmab binds to NGF and helps prevent it from attaching to receptors on nerve cells. By reducing this pain signal, Librela can help decrease osteoarthritis-related pain and improve a dog’s comfort and willingness to move. Librela is intended to control pain. It does not rebuild cartilage or reverse existing joint changes, so it works best alongside appropriate lifestyle and mobility support.
Dogs can respond differently to osteoarthritis pain control. Some dogs show improved comfort within the first week after an injection, while others improve more gradually over several weeks. You may notice that your dog gets up more easily, walks more freely, or is more willing to use stairs and jump. In some dogs, early improvements are subtle, such as settling more comfortably, changing position less often, or seeming less stiff after rest.
Pain control is only one part of arthritis management. Weight management can make a large difference, because even small reductions in excess weight can reduce stress on joints. Regular, controlled exercise often helps maintain joint movement and muscle strength. Many dogs do better with shorter, more frequent walks rather than a single long walk.
Simple home changes can reduce strain and improve confidence. Non-slip mats can help on hard floors. A ramp or step can reduce repeated jumping into the car or onto furniture. A supportive bed in a warm, draught-free area can ease overnight stiffness. Depending on your dog’s needs, your vet may also recommend physiotherapy, hydrotherapy, or a joint supplement.
Librela is a prescription veterinary medicine and should be used under veterinary direction. It is an injectable product and is normally administered by a veterinary professional. Always follow your vet’s guidance about dosing intervals and any other medicines or supplements your dog may be taking. Do not start, stop, or combine pain treatments without professional advice.
You may also like
Arthri-Aid Omega Joint Supplement ArthriAid - 500ml
ArthriAid Omega is a unique combination of high strength Glucosamine, Chondroitin and MSM plus essential co-factors that help encourage the manufacture of new cartilage and synovial fluid leading to easier joint mobility. This is especially important in older active dogs and cats who may be suffering from arthritis or hip dysplasia.
ArthriAid Omega is safe to use in puppies and kittens from 4 weeks of age, being very palatable, it can be given directly from the syringe without any problems.
Flexadin Advanced Chewable Tablets for Dogs - Pack of 30
Flexadin Advanced contains a unique combination of active ingredients that supports cartilage. Pack of 30
180ml Metacam Oral Suspension for Dogs
BD Discardit 2ml Syringe with 21g Needle - each
This 2ml syringe with an attached 21-gauge (21g) needle is suitable for administering specific medications to cats and dogs that require subcutaneous injections. Each syringe is individually packaged, sterile, and designed for single use only. This product is commonly used in veterinary practices and at home under veterinary guidance.
The syringe has a 2ml capacity and is fitted with a 21g needle. This needle size is considered suitable for administering certain subcutaneous or intramuscular injections in cats and dogs, depending on the medication and the animal’s size and condition. The 21g needle offers a balance between needle strength and minimal discomfort during injection, making it appropriate for routine use with specific veterinary biologics.
This type of syringe is appropriate for administering Solensia, Librela, and Cytopoint, which are injectable monoclonal antibody therapies used to manage chronic pain and allergic dermatitis in pets. These medications are typically prescribed for monthly administration and are given via subcutaneous injection. The 21g needle provides a suitable gauge for delivering the full dose efficiently while maintaining comfort for the animal.
Solensia is prescribed for the management of osteoarthritis pain in cats. It is given once a month via subcutaneous injection. The 2ml syringe allows for accurate dosing, and the 21g needle is appropriate for the viscosity of the Solensia solution and for delivering it under the skin in a cat with minimal stress and tissue trauma.
Librela is used in dogs to treat pain associated with osteoarthritis. Like Solensia, it is administered subcutaneously once a month. The 21g needle is appropriate for most dog breeds and sizes, as it enables smooth delivery of the medication while being strong enough to penetrate the skin effectively without bending or breaking.
Cytopoint is another monoclonal antibody therapy, used to manage allergic dermatitis in dogs. It is also given as a monthly subcutaneous injection. The 2ml capacity of the syringe provides ample volume to accommodate the required dose, and the 21g needle is compatible with the formulation’s consistency and administration method.
This syringe and needle combination should not be used for insulin administration in cats or dogs. Veterinary insulin products such as Caninsulin and Prozinc require specific insulin syringes that are calibrated differently from standard 2ml syringes. Insulin syringes are typically marked in units, not millilitres, and have finer, shorter needles such as 29g or 30g, which are designed to deliver precise insulin doses in small volumes. Using a standard 2ml syringe for insulin injections can lead to inaccurate dosing and can be dangerous to the animal.